ArticleScientific reports2025
Association between neutrophil-lymphocyte ratio and all-cause and cardiovascular mortality in osteoarthritis patients from the NHANES 1999-2018 cohort.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Systemic implications of osteoarthritis: from local degeneration to systemic metabolic Dysregulation.Journal of translational medicine · 2026Review
- Association of neutrophil to lymphocyte ratio with the severity of coronary artery lesions in patients undergoing coronary angiography for the first time.Cardiovascular diagnosis and therapy · 2026Article
- Prognostic Value of the Neutrophil-to-Lymphocyte Ratio for All-Cause Mortality in Patients With Cardiovascular-Kidney-Metabolic Stage 4.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This cross-sectional study aimed to investigate the correlation between the neutrophil-lymphocyte ratio (NLR) and all-cause mortality and cardiovascular mortality in osteoarthritis (OA) patients. We involved 3549 adults with OA from the National Health and Nutrition Examination Survey (NHANES) database (1999-2018). The optimal NLR threshold (2.53) was determined using maximally selected rank statistics. Kaplan-Meier (KM), weighted Cox regression, and restricted cubic spline (RCS) analyses were employed to assess the relationship between the NLR and mortality outcomes, with subgroup and sensitivity analyses evaluating the stability of the observed associations. Time-dependent receiver operating characteristic (ROC) curve analysis was conducted to evaluate the NLR prognostic accuracy for mortality across time points. During the 91-month median follow-up period, 843 patients died (256 from cardiovascular disease). Elevated NLR (≥ 2.53) was associated with increased risks of all-cause mortality (HR = 1.82) and cardiovascular mortality (HR = 2.50). Nonlinear correlations of the NLR with mortality outcomes were observed. ROC analysis demonstrated superior NLR predictive capability for all-cause and cardiovascular mortality compared to individual blood cell types. Elevated NLR is independently associated with increased risks of all-cause mortality and cardiovascular mortality in OA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.